As of 2025-09-18, the Relative Valuation of Creo Medical Group PLC (CREO.L) is (139.73) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 12.13 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is -1252.5%.
The range of the Relative Valuation is (134.95) - (145.47) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 37.5x | 30.9x |
| Forward P/E multiples | 20.8x - 29.0x | 24.8x |
| Fair Price | (134.95) - (145.47) | (139.73) |
| Upside | -1213.0% - -1299.8% | -1252.5% |
| Date | P/E |
| 2025-09-18 | -2.41 |
| 2025-09-17 | -2.42 |
| 2025-09-16 | -2.42 |
| 2025-09-15 | -2.44 |
| 2025-09-12 | -2.39 |
| 2025-09-11 | -2.49 |
| 2025-09-10 | -2.52 |
| 2025-09-09 | -2.52 |
| 2025-09-08 | -2.57 |
| 2025-09-05 | -2.59 |
| 2025-09-04 | -2.59 |
| 2025-09-03 | -2.62 |
| 2025-09-02 | -2.62 |
| 2025-09-01 | -2.69 |
| 2025-08-29 | -2.64 |
| 2025-08-28 | -2.62 |
| 2025-08-27 | -2.62 |
| 2025-08-26 | -2.74 |
| 2025-08-22 | -2.74 |
| 2025-08-21 | -2.74 |
| 2025-08-20 | -2.74 |
| 2025-08-19 | -2.74 |
| 2025-08-18 | -2.77 |
| 2025-08-15 | -2.77 |
| 2025-08-14 | -2.62 |
| 2025-08-13 | -2.62 |
| 2025-08-12 | -2.62 |
| 2025-08-11 | -2.62 |
| 2025-08-08 | -2.62 |
| 2025-08-07 | -2.62 |
| 2025-08-06 | -2.63 |
| 2025-08-05 | -2.62 |
| 2025-08-04 | -2.62 |
| 2025-08-01 | -2.49 |
| 2025-07-31 | -2.64 |
| 2025-07-30 | -2.67 |
| 2025-07-29 | -2.72 |
| 2025-07-28 | -2.79 |
| 2025-07-25 | -2.79 |
| 2025-07-24 | -2.79 |
| 2025-07-23 | -2.79 |
| 2025-07-22 | -2.69 |
| 2025-07-21 | -2.59 |
| 2025-07-18 | -2.49 |
| 2025-07-17 | -2.49 |
| 2025-07-16 | -2.52 |
| 2025-07-15 | -2.52 |
| 2025-07-14 | -2.64 |
| 2025-07-11 | -2.57 |
| 2025-07-10 | -2.47 |